Ultimately, we prove evidence that MCT4 is a metabolic vulnerability for BC–CAF crosstalk and that miR-425-5p, by downregulating MCT4, modulates the protumorigenic contribution of CAFs to BC environment and metabolism. Here, SLC16A4 is linked to breast cancer.